Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Head and Neck Neoplasms | 39 | 2023 | 2734 | 3.150 |
Why?
|
Carcinoma, Squamous Cell | 31 | 2023 | 4034 | 1.940 |
Why?
|
Receptors, Bombesin | 2 | 2012 | 27 | 0.850 |
Why?
|
Cyclin B | 2 | 2006 | 108 | 0.540 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2021 | 11524 | 0.450 |
Why?
|
Proto-Oncogene Proteins pp60(c-src) | 2 | 2011 | 146 | 0.410 |
Why?
|
Ear Canal | 1 | 2012 | 146 | 0.390 |
Why?
|
STAT3 Transcription Factor | 3 | 2011 | 873 | 0.370 |
Why?
|
Receptor Cross-Talk | 1 | 2009 | 119 | 0.340 |
Why?
|
Mouth Mucosa | 1 | 2012 | 434 | 0.340 |
Why?
|
Molecular Targeted Therapy | 4 | 2018 | 2727 | 0.320 |
Why?
|
Mouth Neoplasms | 4 | 2022 | 601 | 0.310 |
Why?
|
Bronchi | 1 | 2012 | 840 | 0.310 |
Why?
|
Papillomavirus Infections | 5 | 2023 | 1587 | 0.310 |
Why?
|
Oropharyngeal Neoplasms | 2 | 2023 | 477 | 0.310 |
Why?
|
Gene Amplification | 1 | 2012 | 1063 | 0.300 |
Why?
|
Thiazoles | 2 | 2011 | 1483 | 0.300 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2012 | 388 | 0.290 |
Why?
|
Tumor Microenvironment | 5 | 2023 | 3586 | 0.270 |
Why?
|
Drug Delivery Systems | 2 | 2008 | 2219 | 0.270 |
Why?
|
Antigens, Neoplasm | 2 | 2021 | 1988 | 0.260 |
Why?
|
Receptor, Notch1 | 3 | 2014 | 502 | 0.260 |
Why?
|
Gene Expression Regulation, Neoplastic | 8 | 2021 | 8428 | 0.250 |
Why?
|
Antibodies, Neoplasm | 1 | 2005 | 286 | 0.240 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 2 | 2016 | 489 | 0.230 |
Why?
|
Cancer Vaccines | 2 | 2021 | 1023 | 0.230 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2014 | 2916 | 0.220 |
Why?
|
Pyrimidines | 2 | 2011 | 2942 | 0.210 |
Why?
|
Cell Line, Tumor | 13 | 2022 | 16689 | 0.210 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2022 | 9239 | 0.200 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2023 | 4479 | 0.200 |
Why?
|
Antineoplastic Agents | 7 | 2023 | 13695 | 0.200 |
Why?
|
Receptors, Estrogen | 1 | 2009 | 2187 | 0.200 |
Why?
|
Pyrimidinones | 2 | 2021 | 371 | 0.200 |
Why?
|
Alphapapillomavirus | 2 | 2014 | 221 | 0.180 |
Why?
|
Mutation | 9 | 2021 | 29786 | 0.180 |
Why?
|
Neoplasm Staging | 5 | 2015 | 11031 | 0.180 |
Why?
|
Antibodies, Monoclonal | 3 | 2012 | 9274 | 0.180 |
Why?
|
Signal Transduction | 7 | 2016 | 23403 | 0.170 |
Why?
|
Disease-Free Survival | 4 | 2021 | 6895 | 0.170 |
Why?
|
Protein Kinase Inhibitors | 2 | 2015 | 5535 | 0.160 |
Why?
|
Neoadjuvant Therapy | 4 | 2023 | 2728 | 0.160 |
Why?
|
Sialoglycoproteins | 1 | 2018 | 318 | 0.150 |
Why?
|
Carcinoma | 2 | 2023 | 2375 | 0.150 |
Why?
|
Neoplasm Metastasis | 4 | 2018 | 4851 | 0.150 |
Why?
|
Neoplasms | 3 | 2012 | 21683 | 0.140 |
Why?
|
Humans | 56 | 2023 | 744343 | 0.140 |
Why?
|
Aged | 22 | 2021 | 163280 | 0.140 |
Why?
|
Cyclin B1 | 2 | 2006 | 52 | 0.140 |
Why?
|
Pyridones | 1 | 2021 | 712 | 0.140 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2012 | 1285 | 0.130 |
Why?
|
Middle Aged | 24 | 2023 | 213383 | 0.130 |
Why?
|
Aged, 80 and over | 14 | 2021 | 57776 | 0.130 |
Why?
|
Phosphorylation | 7 | 2015 | 8436 | 0.130 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2014 | 15519 | 0.130 |
Why?
|
Lung Neoplasms | 2 | 2012 | 13102 | 0.120 |
Why?
|
Receptors, Death Domain | 1 | 2014 | 32 | 0.120 |
Why?
|
Female | 32 | 2023 | 380194 | 0.120 |
Why?
|
Collagen Type XI | 1 | 2013 | 20 | 0.120 |
Why?
|
Survival Analysis | 4 | 2018 | 10252 | 0.120 |
Why?
|
Mouth Floor | 1 | 2014 | 34 | 0.120 |
Why?
|
Adenocarcinoma | 1 | 2012 | 6364 | 0.120 |
Why?
|
Male | 30 | 2023 | 350118 | 0.120 |
Why?
|
Genetic Predisposition to Disease | 2 | 2015 | 17446 | 0.120 |
Why?
|
Caspase 8 | 1 | 2014 | 195 | 0.120 |
Why?
|
Neoplasm Invasiveness | 5 | 2018 | 3616 | 0.120 |
Why?
|
Adult | 21 | 2021 | 214055 | 0.120 |
Why?
|
Interferon-gamma | 2 | 2020 | 3206 | 0.120 |
Why?
|
Tongue Neoplasms | 1 | 2015 | 180 | 0.110 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 5221 | 0.110 |
Why?
|
Pancreatic Neoplasms | 1 | 2011 | 5256 | 0.110 |
Why?
|
beta Catenin | 1 | 2018 | 1059 | 0.110 |
Why?
|
Sequence Deletion | 2 | 2015 | 1526 | 0.110 |
Why?
|
Prognosis | 9 | 2023 | 29063 | 0.110 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2014 | 367 | 0.110 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2014 | 417 | 0.110 |
Why?
|
Deglutition | 1 | 2014 | 197 | 0.110 |
Why?
|
DNA Mutational Analysis | 3 | 2021 | 4186 | 0.110 |
Why?
|
Nasal Septum | 1 | 2013 | 127 | 0.110 |
Why?
|
Cholesteatoma, Middle Ear | 1 | 2012 | 49 | 0.100 |
Why?
|
Receptor, Notch2 | 1 | 2012 | 89 | 0.100 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2013 | 234 | 0.100 |
Why?
|
Introns | 1 | 2014 | 991 | 0.100 |
Why?
|
Genes, p53 | 1 | 2014 | 755 | 0.100 |
Why?
|
Transcription Factors | 2 | 2022 | 12208 | 0.100 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2001 | 2455 | 0.100 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2021 | 3557 | 0.100 |
Why?
|
Receptors, CCR7 | 1 | 2011 | 108 | 0.100 |
Why?
|
STAT1 Transcription Factor | 1 | 2013 | 320 | 0.100 |
Why?
|
Nasal Obstruction | 1 | 2013 | 151 | 0.100 |
Why?
|
Neoplasm Proteins | 2 | 2015 | 3703 | 0.100 |
Why?
|
Transforming Growth Factor alpha | 1 | 2011 | 135 | 0.100 |
Why?
|
Exons | 2 | 2015 | 2437 | 0.100 |
Why?
|
Smoking | 4 | 2014 | 8987 | 0.100 |
Why?
|
Codon, Nonsense | 1 | 2012 | 281 | 0.100 |
Why?
|
Hand Strength | 1 | 2014 | 448 | 0.100 |
Why?
|
Neoplasms, Squamous Cell | 1 | 2011 | 96 | 0.100 |
Why?
|
Chloride Channels | 1 | 2012 | 227 | 0.100 |
Why?
|
Case-Control Studies | 3 | 2014 | 21746 | 0.100 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2014 | 312 | 0.100 |
Why?
|
Cell Cycle Proteins | 1 | 2022 | 3462 | 0.090 |
Why?
|
Laryngeal Neoplasms | 1 | 2014 | 512 | 0.090 |
Why?
|
Retinoblastoma Protein | 1 | 2014 | 704 | 0.090 |
Why?
|
Immunotherapy | 2 | 2022 | 4445 | 0.090 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2021 | 5172 | 0.090 |
Why?
|
Genetic Heterogeneity | 1 | 2014 | 733 | 0.090 |
Why?
|
Transcription Factor AP-1 | 1 | 2011 | 317 | 0.090 |
Why?
|
Logistic Models | 3 | 2014 | 13408 | 0.090 |
Why?
|
Rhinoplasty | 1 | 2013 | 226 | 0.090 |
Why?
|
Linkage Disequilibrium | 1 | 2014 | 1997 | 0.090 |
Why?
|
Chromosome Deletion | 1 | 2014 | 1401 | 0.090 |
Why?
|
Genomic Instability | 1 | 2014 | 695 | 0.090 |
Why?
|
DNA, Antisense | 1 | 2009 | 46 | 0.090 |
Why?
|
Frail Elderly | 1 | 2014 | 693 | 0.080 |
Why?
|
Papillomaviridae | 3 | 2023 | 1119 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20129 | 0.080 |
Why?
|
Genes, src | 1 | 2008 | 52 | 0.080 |
Why?
|
RNA, Messenger | 3 | 2013 | 13033 | 0.080 |
Why?
|
Constriction, Pathologic | 1 | 2012 | 1107 | 0.080 |
Why?
|
Deglutition Disorders | 1 | 2014 | 605 | 0.080 |
Why?
|
Cisplatin | 1 | 2014 | 1662 | 0.080 |
Why?
|
Mice, Nude | 4 | 2018 | 3689 | 0.080 |
Why?
|
Hepatocyte Growth Factor | 1 | 2009 | 270 | 0.080 |
Why?
|
Gene Frequency | 1 | 2014 | 3588 | 0.080 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2008 | 88 | 0.080 |
Why?
|
Receptors, Notch | 1 | 2012 | 739 | 0.080 |
Why?
|
Cohort Studies | 7 | 2023 | 40561 | 0.070 |
Why?
|
Radiotherapy | 1 | 2014 | 1533 | 0.070 |
Why?
|
Proteomics | 2 | 2022 | 3638 | 0.070 |
Why?
|
Disease Progression | 5 | 2018 | 13284 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2022 | 5853 | 0.070 |
Why?
|
HLA Antigens | 1 | 2013 | 1381 | 0.070 |
Why?
|
Interleukin-6 | 1 | 2017 | 3200 | 0.070 |
Why?
|
Clinical Trials as Topic | 3 | 2021 | 7913 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2023 | 4838 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2011 | 10943 | 0.070 |
Why?
|
Epidermal Growth Factor | 1 | 2009 | 708 | 0.070 |
Why?
|
Deoxycytidine | 1 | 2011 | 826 | 0.070 |
Why?
|
Walking | 1 | 2014 | 1180 | 0.070 |
Why?
|
Outpatients | 1 | 2014 | 1486 | 0.070 |
Why?
|
Mucous Membrane | 1 | 2009 | 673 | 0.070 |
Why?
|
Ribonuclease III | 1 | 2008 | 275 | 0.070 |
Why?
|
Postoperative Care | 1 | 2012 | 1486 | 0.070 |
Why?
|
Peptide Fragments | 1 | 2018 | 5097 | 0.070 |
Why?
|
Gene Silencing | 1 | 2012 | 1538 | 0.070 |
Why?
|
Monitoring, Immunologic | 1 | 2006 | 100 | 0.070 |
Why?
|
src-Family Kinases | 1 | 2008 | 551 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2009 | 578 | 0.060 |
Why?
|
Ligands | 1 | 2012 | 3282 | 0.060 |
Why?
|
Immunohistochemistry | 4 | 2012 | 11366 | 0.060 |
Why?
|
Genomics | 2 | 2018 | 5720 | 0.060 |
Why?
|
Reference Values | 1 | 2012 | 4982 | 0.060 |
Why?
|
Quinazolines | 1 | 2011 | 1356 | 0.060 |
Why?
|
Esophageal Neoplasms | 1 | 2014 | 1583 | 0.060 |
Why?
|
Salivary Gland Neoplasms | 1 | 2008 | 298 | 0.060 |
Why?
|
ROC Curve | 1 | 2012 | 3527 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2014 | 2948 | 0.060 |
Why?
|
DNA-Binding Proteins | 1 | 2001 | 9648 | 0.060 |
Why?
|
Apoptosis | 3 | 2016 | 9727 | 0.060 |
Why?
|
Animals | 14 | 2022 | 168757 | 0.060 |
Why?
|
Risk Factors | 5 | 2014 | 72290 | 0.060 |
Why?
|
Base Sequence | 1 | 2015 | 12797 | 0.060 |
Why?
|
Risk Assessment | 3 | 2014 | 23338 | 0.060 |
Why?
|
Mice | 9 | 2022 | 81183 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2012 | 6365 | 0.060 |
Why?
|
Gene Targeting | 1 | 2006 | 880 | 0.060 |
Why?
|
NF-kappa B | 1 | 2011 | 2499 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2012 | 2564 | 0.050 |
Why?
|
Young Adult | 6 | 2014 | 56430 | 0.050 |
Why?
|
Estrogens | 1 | 2009 | 1566 | 0.050 |
Why?
|
Medical Informatics | 1 | 2009 | 745 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 2942 | 0.050 |
Why?
|
Predictive Value of Tests | 4 | 2015 | 15076 | 0.050 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2023 | 338 | 0.050 |
Why?
|
Point Mutation | 2 | 2011 | 1623 | 0.050 |
Why?
|
Leukoplakia, Oral | 1 | 2021 | 73 | 0.050 |
Why?
|
Human papillomavirus 16 | 1 | 2023 | 262 | 0.050 |
Why?
|
Lymph Nodes | 1 | 2012 | 3474 | 0.050 |
Why?
|
Cell Nucleus | 1 | 2010 | 2969 | 0.050 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4328 | 0.050 |
Why?
|
Vaccines, Subunit | 1 | 2021 | 168 | 0.050 |
Why?
|
Trypsin | 1 | 2001 | 511 | 0.050 |
Why?
|
Precipitin Tests | 1 | 2001 | 829 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2014 | 14722 | 0.050 |
Why?
|
Promoter Regions, Genetic | 1 | 2011 | 5867 | 0.050 |
Why?
|
Genotype | 1 | 2014 | 12951 | 0.040 |
Why?
|
Sequence Analysis, DNA | 1 | 2011 | 4803 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 1 | 2012 | 4554 | 0.040 |
Why?
|
Phenylalanine | 1 | 2001 | 365 | 0.040 |
Why?
|
Treatment Outcome | 5 | 2021 | 63114 | 0.040 |
Why?
|
Risk | 1 | 2012 | 9687 | 0.040 |
Why?
|
Keratinocytes | 2 | 2014 | 798 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2020 | 3479 | 0.040 |
Why?
|
Vaccines, DNA | 1 | 2021 | 305 | 0.040 |
Why?
|
COS Cells | 1 | 2001 | 1161 | 0.040 |
Why?
|
Neoplasm Transplantation | 2 | 2015 | 2085 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2001 | 575 | 0.040 |
Why?
|
Decision Making | 1 | 2012 | 3887 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 3870 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12245 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2021 | 809 | 0.040 |
Why?
|
Cell Proliferation | 4 | 2018 | 10481 | 0.040 |
Why?
|
Internet | 1 | 2009 | 3064 | 0.040 |
Why?
|
Genes, Reporter | 1 | 2001 | 1547 | 0.040 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2021 | 1475 | 0.040 |
Why?
|
DNA, Viral | 1 | 2023 | 2225 | 0.040 |
Why?
|
Tyrosine | 1 | 2001 | 1461 | 0.040 |
Why?
|
Biopsy | 2 | 2021 | 6756 | 0.030 |
Why?
|
Cell Movement | 3 | 2014 | 5217 | 0.030 |
Why?
|
Plasmids | 1 | 2001 | 2307 | 0.030 |
Why?
|
Prospective Studies | 4 | 2023 | 53288 | 0.030 |
Why?
|
Child, Preschool | 3 | 2014 | 41006 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2022 | 77449 | 0.030 |
Why?
|
Salvage Therapy | 1 | 2021 | 1275 | 0.030 |
Why?
|
Transfection | 2 | 2001 | 5892 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2001 | 1783 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1038 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2011 | 7880 | 0.030 |
Why?
|
Epitopes | 1 | 2001 | 2571 | 0.030 |
Why?
|
Databases, Factual | 1 | 2009 | 7729 | 0.030 |
Why?
|
Protein Structure, Tertiary | 1 | 2001 | 3846 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2013 | 3505 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2021 | 9438 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2021 | 1526 | 0.030 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2014 | 323 | 0.030 |
Why?
|
Pneumonia, Aspiration | 1 | 2014 | 145 | 0.030 |
Why?
|
Viper Venoms | 1 | 1992 | 14 | 0.030 |
Why?
|
Lung | 1 | 2012 | 9856 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2013 | 399 | 0.030 |
Why?
|
Pennsylvania | 1 | 2014 | 613 | 0.030 |
Why?
|
Cell Line | 2 | 2012 | 15997 | 0.030 |
Why?
|
Receptors, Endothelin | 1 | 1992 | 58 | 0.030 |
Why?
|
Cell Transformation, Viral | 1 | 2014 | 565 | 0.030 |
Why?
|
Endothelins | 1 | 1992 | 138 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2022 | 21827 | 0.030 |
Why?
|
Binding Sites | 1 | 2001 | 6114 | 0.030 |
Why?
|
Enzyme Induction | 1 | 2012 | 475 | 0.030 |
Why?
|
Models, Biological | 1 | 2008 | 9583 | 0.030 |
Why?
|
Cell Adhesion | 1 | 2018 | 3144 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2001 | 6622 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 25043 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2934 | 0.020 |
Why?
|
Malaria, Cerebral | 1 | 2011 | 135 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 2018 | 1376 | 0.020 |
Why?
|
Aspartic Acid | 1 | 1992 | 576 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2022 | 11483 | 0.020 |
Why?
|
Remission Induction | 1 | 2015 | 2386 | 0.020 |
Why?
|
Phenotype | 2 | 2018 | 16365 | 0.020 |
Why?
|
Vaccination | 1 | 2021 | 3278 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2001 | 13815 | 0.020 |
Why?
|
Escherichia coli | 1 | 2001 | 4217 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1655 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2013 | 1730 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 8642 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2015 | 2715 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2021 | 4386 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2015 | 1783 | 0.020 |
Why?
|
Proteins | 1 | 2023 | 6103 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3597 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2010 | 553 | 0.020 |
Why?
|
Esophagus | 1 | 2014 | 1019 | 0.020 |
Why?
|
Cell Survival | 1 | 2018 | 5882 | 0.020 |
Why?
|
GTP-Binding Proteins | 1 | 1992 | 970 | 0.020 |
Why?
|
Neck | 1 | 2012 | 697 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2016 | 6314 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2001 | 18111 | 0.020 |
Why?
|
Age Distribution | 1 | 2014 | 2902 | 0.020 |
Why?
|
Survival Rate | 2 | 2014 | 12788 | 0.020 |
Why?
|
Lysine | 1 | 1992 | 1007 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2001 | 4665 | 0.020 |
Why?
|
Deafness | 1 | 2012 | 458 | 0.020 |
Why?
|
Paracrine Communication | 1 | 2009 | 277 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2014 | 39050 | 0.020 |
Why?
|
Automation | 1 | 2010 | 584 | 0.020 |
Why?
|
Inhibitory Concentration 50 | 1 | 2008 | 459 | 0.020 |
Why?
|
Treatment Failure | 1 | 2013 | 2618 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2012 | 973 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2001 | 7722 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4933 | 0.020 |
Why?
|
Zebrafish | 1 | 2018 | 2994 | 0.020 |
Why?
|
Viral Proteins | 1 | 2014 | 1900 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2010 | 1799 | 0.020 |
Why?
|
Exercise Test | 1 | 2014 | 2074 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2014 | 2007 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2018 | 3690 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2012 | 3701 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2012 | 2649 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2010 | 2505 | 0.020 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2013 | 1821 | 0.020 |
Why?
|
Down-Regulation | 1 | 2013 | 3002 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2012 | 2924 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4751 | 0.020 |
Why?
|
Cell Division | 1 | 2012 | 4568 | 0.020 |
Why?
|
Protein Transport | 1 | 2010 | 1988 | 0.010 |
Why?
|
Stress, Mechanical | 1 | 2009 | 1686 | 0.010 |
Why?
|
Reoperation | 1 | 2013 | 4201 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2022 | 18029 | 0.010 |
Why?
|
Tumor Burden | 1 | 2009 | 1915 | 0.010 |
Why?
|
Recovery of Function | 1 | 2013 | 2925 | 0.010 |
Why?
|
Hypersensitivity | 1 | 2011 | 1102 | 0.010 |
Why?
|
Up-Regulation | 1 | 2011 | 4217 | 0.010 |
Why?
|
Recurrence | 1 | 2014 | 8340 | 0.010 |
Why?
|
Blotting, Western | 1 | 2009 | 5179 | 0.010 |
Why?
|
Infant | 2 | 2014 | 35136 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2013 | 3396 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2009 | 2382 | 0.010 |
Why?
|
Piperidines | 1 | 2009 | 1602 | 0.010 |
Why?
|
Indoles | 1 | 2009 | 1839 | 0.010 |
Why?
|
Data Collection | 1 | 2009 | 3341 | 0.010 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2009 | 2016 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2009 | 2503 | 0.010 |
Why?
|
Adolescent | 3 | 2014 | 85781 | 0.010 |
Why?
|
Sulfonamides | 1 | 2009 | 1938 | 0.010 |
Why?
|
Child | 3 | 2014 | 77709 | 0.010 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2011 | 2104 | 0.010 |
Why?
|
Pyrazoles | 1 | 2009 | 1972 | 0.010 |
Why?
|
Piperazines | 1 | 2009 | 2488 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2008 | 3420 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2015 | 9959 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 19229 | 0.010 |
Why?
|
Computational Biology | 1 | 2009 | 3521 | 0.010 |
Why?
|
Pyridines | 1 | 2009 | 2825 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2012 | 14557 | 0.010 |
Why?
|
Multiple Sclerosis | 1 | 2011 | 3079 | 0.010 |
Why?
|
Body Mass Index | 1 | 2014 | 12720 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15540 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 2011 | 3712 | 0.010 |
Why?
|
Incidence | 1 | 2014 | 20947 | 0.010 |
Why?
|
United States | 2 | 2014 | 69872 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2014 | 19905 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2014 | 25625 | 0.010 |
Why?
|
Time Factors | 1 | 2015 | 40075 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2010 | 8949 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2009 | 6234 | 0.010 |
Why?
|
Inositol Phosphates | 1 | 1992 | 180 | 0.010 |
Why?
|
MicroRNAs | 1 | 2008 | 3752 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1992 | 1157 | 0.010 |
Why?
|
Algorithms | 1 | 2011 | 13881 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2012 | 15295 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1992 | 1723 | 0.010 |
Why?
|
Iodine Radioisotopes | 1 | 1992 | 1032 | 0.010 |
Why?
|
HIV Infections | 1 | 2011 | 16718 | 0.000 |
Why?
|
Polymerase Chain Reaction | 1 | 1992 | 6171 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1992 | 8301 | 0.000 |
Why?
|
DNA | 1 | 1992 | 7301 | 0.000 |
Why?
|
Rats | 1 | 1992 | 24260 | 0.000 |
Why?
|
Brain | 1 | 1992 | 26385 | 0.000 |
Why?
|